Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of IABP in the Early Stage of Acute Myocardial Infarction With Cardiogenic Shock (SCAI-B): a Multicenter, Prospective, Randomized Controlled Study

NCT04989777 is registered in ClinicalTrials.gov with Renmin Hospital of Wuhan University as lead sponsor.

NCT NCT04989777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04989777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of IABP in the Early Stage of Acute Myocardial Infarction With Cardiogenic Shock (SCAI-B): a Multicenter, Prospective, Randomized Controlled Study
Lead sponsor
Renmin Hospital of Wuhan University
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2022
Completion date
January 1, 2026
Enrollment
512 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiogenic shock, myocardial infarction, acute